ScripsAmerica Company Profile (OTCMKTS:SCRC)

About ScripsAmerica (OTCMKTS:SCRC)

ScripsAmerica logoScripsAmerica, Inc. is engaged in the distribution of prescription and over the counter pharmaceuticals. The Company's subsidiaries include Main Avenue Pharmacy Inc. (Main Avenue), DispenseDoc Inc. (DispenseDoc) and Pharmacy Administration, Inc. (Pharmacy Administration). It also holds interests in P.I.M.D. International LLC (PIMD). Its operations consist of the sale and compounding of non-sterile topical and transdermal pain creams through Main Avenue; wholesale sales to independent pharmacies and other medical providers through PIMD; pharmacy dispensing services for individual doctors through DispenseDoc, and billing and administrative services through Pharmacy Administration. Main Avenue's prescription pain creams incorporate approximately eight active pharmaceutical ingredients for application on the skin and in localized areas. As of December 31, 2014, PIMD held licenses in over 20 states to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:SCRC
  • CUSIP: N/A
  • Web:
Average Prices:
  • 52 Week Range: $0.01 - $0.07
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 0.20
  • P/E Growth: 0
  • Net Margins: -17.48%
  • Return on Assets: -125.08%
  • Beta: -1.38

Frequently Asked Questions for ScripsAmerica (OTCMKTS:SCRC)

What is ScripsAmerica's stock symbol?

ScripsAmerica trades on the OTCMKTS under the ticker symbol "SCRC."

Who are some of ScripsAmerica's key competitors?

Who are ScripsAmerica's key executives?

ScripsAmerica's management team includes the folowing people:

  • Brian Ettinger, Chairman of the Board, Chief Executive Officer
  • Adam Brosius, President, Director
  • Jeffrey J. Andrews, Chief Financial Officer
  • Pelligrino L. Certa, Director
  • Joseph Camardo M.D., Independent Director
  • Michael Imperiale M.D., Independent Director
  • William Austin Lewis IV, Independent Director
  • Andrius Pranskevicius, Independent Director

How do I buy ScripsAmerica stock?

Shares of ScripsAmerica can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ScripsAmerica's stock price today?

One share of ScripsAmerica stock can currently be purchased for approximately $0.00.

MarketBeat Community Rating for ScripsAmerica (OTCMKTS SCRC)
Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  13 (Vote Outperform)
Underperform Votes:  11 (Vote Underperform)
Total Votes:  24
MarketBeat's community ratings are surveys of what our community members think about ScripsAmerica and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for ScripsAmerica (OTCMKTS:SCRC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for ScripsAmerica (OTCMKTS:SCRC)
No equities research coverage for this company has been tracked by


Earnings History for ScripsAmerica (OTCMKTS:SCRC)
No earnings announcements for this company have been tracked by


Earnings Estimates for ScripsAmerica (OTCMKTS:SCRC)
Current Year EPS Consensus Estimate: $0.010 EPS
Next Year EPS Consensus Estimate: $0.010 EPS


Dividend History for ScripsAmerica (OTCMKTS:SCRC)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for ScripsAmerica (OTCMKTS:SCRC)
Insider Trades by Quarter for ScripsAmerica (OTCMKTS:SCRC)
Insider Trades by Quarter for ScripsAmerica (OTCMKTS:SCRC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/10/2016Steve UrbanskiMajor ShareholderSell100,000$0.04$4,000.00View SEC Filing  
1/28/2016Steve Urbanskimajor shareholderSell1,020,000$0.03$30,600.00View SEC Filing  
12/16/2015Robert SchneidermanMajor ShareholderSell1,450,000$0.02$29,000.00View SEC Filing  
6/11/2015Steve UrbanskiMajor ShareholderSell182,843$0.07$12,799.01View SEC Filing  
4/28/2015Steve UrbanskiMajor ShareholderSell50,000$0.10$5,000.00View SEC Filing  
4/9/2015Steve UrbanskiMajor ShareholderSell53,500$0.07$3,745.00View SEC Filing  
12/12/2014Steve UrbanskiMajor ShareholderSell200,000$0.18$36,000.00View SEC Filing  
10/10/2014Steve UrbanskiMajor ShareholderSell80,000$0.09$7,200.00View SEC Filing  
9/17/2014Brian W AndersonDirectorSell26,000$0.10$2,600.00View SEC Filing  
9/8/2014Brian W AndersonDirectorSell50,000$25.00$1,250,000.00View SEC Filing  
6/12/2014Steve UrbanskiMajor ShareholderSell73,226$0.13$9,519.38View SEC Filing  
5/8/2014Steve UrbanskiMajor ShareholderSell120,000$0.11$13,200.00View SEC Filing  
11/20/2013Steve UrbanskiMajor ShareholderSell89,250$0.15$13,387.50View SEC Filing  
10/30/2013Steve UrbanskiMajor ShareholderSell241,000$0.31$74,710.00View SEC Filing  
9/12/2013Jeff AndrewsCFOSell100,000$0.10$10,000.00View SEC Filing  
6/17/2013Brian W AndersonDirectorSell25,700$0.20$5,140.00View SEC Filing  
6/10/2013Brian W AndersonDirectorSell20,000$0.18$3,600.00View SEC Filing  
5/23/2013Brian W AndersonDirectorSell10,600$0.14$1,484.00View SEC Filing  
9/18/2012Michael ImperialeDirectorSell11,000$0.45$4,950.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for ScripsAmerica (OTCMKTS:SCRC)
Latest Headlines for ScripsAmerica (OTCMKTS:SCRC)
DateHeadline logoSCRIPSAMERICA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events - July 20 at 3:35 PM logoScripsAmerica Highlights Revenue Growth and Market Expansion of Subsidiary PIMD International LLC - June 14 at 8:30 AM logoScripsAmerica Provides Shareholder Update Highlighting Revenue Growth and Expansion of its Specialty Pharmacy Operations - May 11 at 8:30 AM logoSCRIPSAMERICA, INC. Files SEC form 10-Q, Quarterly Report - April 4 at 3:17 PM logoSCRIPSAMERICA, INC. Financials - February 4 at 1:04 PM logoScripsAmerica Announces Filing of 10K Annual Report for Fiscal Year 2014 - February 1 at 8:30 AM logoSCRIPSAMERICA, INC. Files SEC form 10-K, Annual Report - January 29 at 3:53 PM logoSCRIPSAMERICA, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year - January 4 at 1:03 PM logoSCRIPSAMERICA, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhib - August 4 at 10:55 AM logoSCRIPSAMERICA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal - July 6 at 4:53 PM logoIronridge Global IV, Ltd. Prevails Against Claims of Federal Securities Law Violations - July 1 at 8:00 AM logoSCRIPSAMERICA, INC. Files SEC form 8-K, Change in Directors or Principal Officers - May 29 at 4:27 PM logoSeeThruEquity Issues Update Note on ScripsAmerica Highlighting Strong Revenue Growth in 2014 - April 27 at 9:00 AM logoScripsAmerica Featured by Leading Microcap and Emerging Growth Financial News Site - March 23 at 8:00 AM logoScripsAmerica Provides Highlights of Upcoming Presentation - March 18 at 8:00 AM logoScripsAmerica to Present at the Wall Street Analyst Forum's 25th Annual Institutional Investor Conference - March 11 at 8:00 AM logoSCRIPSAMERICA, INC. Files SEC form 8-K, Other Events - March 6 at 4:32 PM logoScripsAmerica Announces Letter of Intent to Acquire Equity Interests in Two Pharmacies, Expanding Specialty Pharmacy Operations into 30 Additional States - March 6 at 4:01 PM Recent News and Interviews - February 23 at 9:15 AM logoScripsAmerica Appoints Gregory FCA as Investor Relations Agency of Record - February 17 at 8:00 AM logoScripsAmerica CEO Bob Schneiderman Featured on “Executive Leaders Radio” - February 12 at 8:00 AM



ScripsAmerica (SCRC) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by Staff